药物预防甲状腺手术切口粘连的探讨  

Prevention of incision adhesion in thyroid surgery

作　　者：程占刚[1] 侯玉波[1] 程天军[1] 杨国兴[1] 

机构地区：[1]河北省玉田县医院耳鼻咽喉头颈外科,河北玉田064100

出　　处：《中国耳鼻咽喉头颈外科》2007年第6期336-337,共2页Chinese Archives of Otolaryngology-Head and Neck Surgery

摘　　要：目的探讨糜蛋白酶、玻璃酸钠对甲状腺手术切口粘连的预防作用。方法将甲状腺手术患者随机分成糜蛋白酶组、玻璃酸钠组、生理盐水组及对照组,术后2、4、6、12个月后进行随访观察切口粘连情况。结果前三组与对照组的粘连发生率差异有统计学意义(P<0.05)。结论药物干预可以减少甲状腺手术切口粘连。OBJECTIVE To evaluate the Chymotrypsin and Hyaluronidase in prevention of incision adhesion in thyroid surgery. METHODS Patients underwent thyroid surgery were randomly divided into 4 groups： Chymotrypsin group, Hyaluronidase group, Normal solution group and Control group. The incision were observed at 2, 4, 6, 12 months after operation. RESULTS The incision adhesion incidences in the first 3 groups were significantly different compared with that in control group （P〈0.05）. CONCLUSION The medicine can decrease the incision adhesion incidence in thyroid surgery.

关 键 词：糜蛋白酶 玻璃酸钠 甲状腺切除术 

分 类 号：R653[医药卫生—外科学]